This product is a vaccine indicated for the prevention of itcoccal itnia and any other serious itcoccal infection (such as septicaemia or meningitis) caused by the types of itcocci (Streptococcus itniae) contained in the vaccine. it is particularly indicated in subjects over 2 years of age with an increased risk of itcoccal infection or associated complications. People at risk who need to be vaccinated are determined in according with official recommendations. This vaccine is not efficacious in the prevention of acute otitis media, sinusitis and other common infections of the upper respiratory tract.
Vaccines, Anti-sera & Immunoglobulin
Dosage You or your child will receive a dose of 0.5 ml as an injection for the first vaccination (primary vaccination). Method of administration Administration by the intramuscular (IM) route is preferable. The subcutaneous (SC) route may also be used. Frequency of administration On the basis of current knowledge, the systematic revaccination of subjects who have received a first vaccination (primary vaccination) is not recommended. The timescale and need for revaccination should be determined in accordance with official recommendations. If revaccination is necessary, you or your child will receive a dose of 0.5 ml per injection.
if you or you or if you or your child developed an allergic reaction following a previous injection of it or a vaccine with a similar composition. ? if you or your child have an infection with a high temperature. In this case, vaccination should be postponed until you or your child have recovered.
The following side effects have been reported with it , based on spontaneous post-marketing reports. It is not possible to calculate exactly how frequently they occur. These side effects have been reported in vary rare cases (less than 1 person in every 10,000). Of these side effects, fever and local reactions at the injection side are the most frequent. ? Swollen glands (lymphadenopathy) ? Headaches ? Convulsions following a high fever (febrile convulsions), especially in children ? Generalized skin eruption (rash), urticaria ? Muscular pain (myalgia), joint pain (arthralgia) ? Inflammation of a deep layer of the skin (cellulitis) at the injection site ? Reactions at the injection site such as: pain, redness, swelling and hardening ? Swelling of the vaccinated limb ? Fever ? Feeling of tiredness ? Feeling generally unwell ? Local inflammatory reaction around the injection site (Arthus-type reaction): pain, swelling, hardening (induration), which may be intense. These reactions are reversible, have no lasting effects and generally appear in people who have an initially high level of anti-itcoccal antibodies. If any of the side effects gets serious or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.
Pregnancy ? In animals, there are no data concerning the possible risks of malformations. ? In humans, there are no sufficiently relevant data enabling the assessment of possible risks of malformations or foetal toxicity related to the administration of the vaccine during pregnancy. As a precautionary measure, avoid prescribing this vaccine to pregnant women except in high-risk situations. Breastfeeding This vaccine can be used during breast-feeding.
.png&w=384&q=75)